000145040 001__ 145040
000145040 005__ 20260112133235.0
000145040 0247_ $$2doi$$a10.3390/jpm14070713
000145040 0248_ $$2sideral$$a139869
000145040 037__ $$aART-2024-139869
000145040 041__ $$aeng
000145040 100__ $$aBarrueco, Enrique
000145040 245__ $$aDiagnosis of Anxiety in COPD Patients: Usefulness of the HADS Test in Primary Care and Pulmonology Services
000145040 260__ $$c2024
000145040 5060_ $$aAccess copy available to the general public$$fUnrestricted
000145040 5203_ $$aAnxiety disorders, characterized by excessive fear and anxiety, are increasingly recognized as significant comorbidities in chronic diseases such as chronic obstructive pulmonary disease (COPD). This study aimed to evaluate the prevalence of anxiety in COPD patients referred from primary care centers to pulmonology services and to identify predictive factors for anxiety. This was a multicentric, observational, and prospective study in which 293 COPD patients were recruited, and they underwent comprehensive respiratory and smoking histories, spirometry, and anxiety assessments using the Hospital Anxiety and Depression Scale (HADS). The results showed a diagnosis of suspected anxiety in 85 patients (29.0%): 17 possible and 68 with a strong suspicion. The study found significant associations between anxiety and factors such as gender (women had a risk that was 3.5 times higher than men), weight, and body mass index (BMI). Disease severity, smoking status, and clinical manifestations did not significantly influence anxiety prevalence. These findings underscore the need for systematic psychological evaluations in COPD management and support the use of simple diagnostic tools like the HADS to facilitate referrals to mental health services. Addressing anxiety in COPD patients could potentially improve their quality of life and disease outcomes. This study highlights the importance of a multidisciplinary approach involving family medicine, pulmonology, and psychiatry to optimize COPD patient care and suggests that future research should focus on the impact of anxiety treatment on COPD progression. These insights call for integrating psychological assessments into routine clinical practice for comprehensive COPD management. The registration number is 10.14201/gredos.148549.
000145040 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttps://creativecommons.org/licenses/by/4.0/deed.es
000145040 592__ $$a0.863$$b2024
000145040 593__ $$aMedicine (miscellaneous)$$c2024$$dQ2
000145040 594__ $$a6.0$$b2024
000145040 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000145040 700__ $$aHernández-Mezquita, Miguel A.
000145040 700__ $$aHidalgo-Sierra, Vanesa
000145040 700__ $$aCordovilla, Rosa
000145040 700__ $$0(orcid)0000-0001-9243-0339$$aOlivera-Pueyo, Javier$$uUniversidad de Zaragoza
000145040 700__ $$aGalán, Javier
000145040 7102_ $$11007$$2745$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Psiquiatría
000145040 773__ $$g14, 7 (2024), 713 [8 pp.]$$pJ. pers. med.$$tJournal of Personalized Medicine$$x2075-4426
000145040 8564_ $$s250926$$uhttps://zaguan.unizar.es/record/145040/files/texto_completo.pdf$$yVersión publicada
000145040 8564_ $$s2610090$$uhttps://zaguan.unizar.es/record/145040/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000145040 909CO $$ooai:zaguan.unizar.es:145040$$particulos$$pdriver
000145040 951__ $$a2026-01-12-12:50:53
000145040 980__ $$aARTICLE